Global Animal Products, Inc. – Trademark Portfolio
Entity Type: 03
Global Animal Products, Inc. holds 22 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 19 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 12 trademarks are registered. Notable registered marks include G, LT4, CUBET, FEMET, and Z-BET. The owner is based in Amarillo, TX.
3701 Airway Boulevard
Amarillo, TX 79118
Showing of trademarks Trademarks
Trademark Classifications
Global Animal Products, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademarks does Global Animal Products, Inc. have?
Global Animal Products, Inc. has 22 U.S. trademarks filed with the USPTO. Of these, 12 registered, 4 abandoned, 6 cancelled.
What trademark classes does Global Animal Products, Inc. file in?
Global Animal Products, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 31 (Natural Agricultural Products). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Global Animal Products, Inc.'s most well-known trademarks?
Global Animal Products, Inc.'s registered trademark portfolio includes well-known marks such as G, LT4, CUBET, FEMET, and Z-BET. These are among 12 currently registered trademarks in the portfolio.
What is Global Animal Products, Inc.'s trademark registration success rate?
Global Animal Products, Inc. has a 55% trademark registration rate, with 12 out of 22 resolved applications resulting in successful registration. Currently, 0 applications are pending review.